Do you typically categorize keratoacanthomas as a distinct entity from squamous cell carcinomas, and do you favor medical treatment vs surgery?   

I consider keratoacanthoma (KA) to be a well-differentiated, low-risk subtype of squamous cell carcinoma (SCC). I will counsel patients on the risks and benefits of medical treatment and surgical treatment. There are several factors to consider such as patient age, location and size of the lesion, ...

I know this entity has multiple treatment options. Having tried almost everything, I believe the faster the KA is definitively excised, the better the outcome for the patient. It’s a space-occupying lesion, and spontaneous resolution/watchful waiting simply isn’t an option almost ever in...